Health inequalities, diagnostic overshadowing, and recognising concerns

People with a learning disability often have poorer physical and mental health than the wider population. They may find it harder to recognise when they are unwell, to explain symptoms clearly, or to get mainstream services to respond quickly and appropriately.

What pharmacy teams need to watch for

• Pain or discomfort that is not clearly described: agitation, withdrawal, sleep change, refusal, or repeated OTC purchases may sometimes be the clue.
• Repeated constipation, reflux, swallowing difficulty, or sedation: these may be related to medicines, diet, mobility, or unmet medical need and should not be dismissed.
• Behaviour change: distress, aggression, pacing, or refusal may be linked to pain, fear, infection, side effects, or communication difficulty rather than "bad behaviour".
• Missed or delayed care: the person may not attend reviews, may miss routine monitoring, or may not be getting health information in a format they can use.
• Hidden vulnerability: some people appear settled until there is a change in routine, a medicine problem, a safeguarding issue, or the loss of a familiar supporter.

Diagnostic overshadowing

Diagnostic overshadowing means assuming that symptoms, distress, or behaviour are caused by the person's learning disability instead of considering whether there is a separate physical or mental health problem. This can delay diagnosis and treatment.

For pharmacy teams, this matters when recurring pain, constipation, reflux, sedation, sleep disturbance, poor appetite, swallowing problems, or sudden distress are being normalised rather than reviewed properly.

People with a learning disability get the same illnesses as everyone else. If symptoms, distress, or behaviour change are simply attributed to the learning disability, important illness can be missed.